The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 1×
“Neuropathology revealed signiWcantly more severe AD-type pathology (both neuritic Braak stages and cortical A plaque load), and generalized CAA, while the LB pathology scores [11] were only moderately increased in PDD brains (28% with score 5 and 6 vs.”
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“A large retrospective study of 617 autopsy-proven cases of PD (Lewy body disease of brainstem type [73]) showed a signiWcantly higher frequency of CVLs than in 535 age-matched controls (44.”
Self-citationMutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611
The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity
Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068
Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein
Giasson, B. I., Forman, M. S., Higuchi, M., Golbe, L. I., Graves, C. L., Kotzbauer, P. T., Trojanowski, J. Q., & Lee, V. M.-Y. (2003) · Science · doi:10.1126/science.1082324 · Cited by 879 · cited 1×
“... disorders [57, 78], and the association between dopaminergic neuronal degeneration, accumulation of Syn and tau or both proteins in LRRK2 mutations [1, 29, 102], induction of hyperphosphorylation of tau by Syn in the MPTP model of parkinsonism [23], and the association of atypical protein kinase C (aPKC) and phosp…”
BackgroundAlzheimer Disease as a Vascular Disorder: Nosological Evidence
de la Torre, J. C. (2002) · Stroke · doi:10.1161/01.str.0000014421.15948.67 · Cited by 853
Hamilton, R. L. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00269.x · Cited by 754
Burton, E. J. (2004) · Brain · doi:10.1093/brain/awh088 · Cited by 647
Braak, H., Bohl, J. R., Müller, C. M., Rüb, U., de Vos, R. A. I., & Del Tredici, K. (2006) · Movement Disorders · doi:10.1002/mds.21065 · Cited by 630
Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., & Mucke, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211412398 · Cited by 607
Cognitive status correlates with neuropathologic stage in Parkinson disease
Braak, H., Rüb, U., Jansen Steur, E. N. H., Del Tredici, K., & de Vos, R. A. I. (2005) · Neurology · doi:10.1212/01.wnl.0000158422.41380.82 · Cited by 560
Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug Discovery
Lee, V. M.-Y., & Trojanowski, J. Q. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.026 · Cited by 479
Premkumar, D. R., Cohen, D., Hedera, P., Friedland, R. P., & Kalaria, R. N. (1996) · Europe PMC (PubMed Central) · Cited by 408
Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies
Ishizawa, T., Mattila, P., Davies, P., Wang, D., & Dickson, D. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.389 · Cited by 394
Sequence of Aβ-protein deposition in the human medial temporal lobe
Thal, D. R., Rüb, U., Schultz, C., Sassin, I., Ghebremedhin, E., Del Tredici, K., Braak, E., & Braak, H. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.8.733 · Cited by 370
Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of α-Synucleinopathy
Uchikado, H., Lin, W.-L., DeLucia, M. W., & Dickson, D. W. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000225908.90052.07 · Cited by 359
Accumulation of Phosphorylated α-Synuclein in Aging Human Brain
Saito, Y., Kawashima, A., Ruberu, N. N., Fujiwara, H., Koyama, S., Sawabe, M., Arai, T., Nagura, H., Yamanouchi, H., Hasegawa, M., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.644 · Cited by 351
The role of α-synuclein in Parkinson's disease: insights from animal models
Maries, E., Dass, B., Collier, T. J., Kordower, J. H., & Steece-Collier, K. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1199 · Cited by 344
Parkinson's disease is associated with hippocampal atrophy
Camicioli, R., Moore, M. M., Kinney, A., Corbridge, E., Glassberg, K., & Kaye, J. A. (2003) · Movement Disorders · doi:10.1002/mds.10444 · Cited by 343
Blood–Brain Barrier Pathology in Alzheimer's and Parkinson's Disease: Implications for Drug Therapy
Desai, B. S., Monahan, A. J., Carvey, P. M., & Hendey, B. (2007) · Cell Transplantation · doi:10.3727/000000007783464731 · Cited by 339
Clearing amyloid through the blood-brain barrier
Zlokovic, B. V. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02385.x · Cited by 336
Amyloid Angiopathy–Related Vascular Cognitive Impairment
Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298
Cerebral atrophy and its relation to cognitive impairment in Parkinson disease
Nagano-Saito, A., Washimi, Y., Arahata, Y., Kachi, T., Lerch, J. P., Evans, A. C., Dagher, A., & Ito, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149510.41793.50 · Cited by 284
Neuropathological evaluation of mixed dementia
Jellinger, K. A., & Attems, J. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.045 · Cited by 272
Self-citationClinical phenotype of Parkinson disease dementia
Galvin, J. E., Pollack, J., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242630.52203.8f · Cited by 265
Interface between tauopathies and synucleinopathies: A tale of two proteins
Galpern, W. R., & Lang, A. E. (2006) · Annals of Neurology · doi:10.1002/ana.20819 · Cited by 263
Rogers, J., Mastroeni, D., Leonard, B., Joyce, J., & Grover, A. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82012-5 · Cited by 260
Lewy body-related ?-synucleinopathy in the aged human brain
Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 256
Self-citationSporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms
Attems, J. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1074-9 · Cited by 242 · cited 1×
“The severity of generalized CAA was semiquantitatively assessed similar to the method described by Olichney et al. [80] (see also [ 3 ]).”
MethodSelf-citationBiochemical and pathological characterization of Lrrk2
Giasson, B. I., Covy, J. P., Bonini, N. M., Hurtig, H. I., Farrer, M. J., Trojanowski, J. Q., & Van Deerlin, V. M. (2006) · Annals of Neurology · doi:10.1002/ana.20791 · Cited by 238
Mortality in Parkinson's disease and its association with dementia and depression
Hughes, T. A., Ross, H. F., Mindham, R. H. S., & Spokes, E. G. S. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00292.x · Cited by 220
Mandal, P. K., Pettegrew, J. W., Masliah, E., Hamilton, R. L., & Mandal, R. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9140-9 · Cited by 219
Olichney, J. M., Hansen, L. A., Galasko, D., Saitoh, T., Hofstetter, C. R., Katzman, R., & Thal, L. J. (1996) · Neurology · doi:10.1212/wnl.47.1.190 · Cited by 216
The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease
Bailey, T. L., Rivara, C. B., Rocher, A. B., & Hof, P. R. (2004) · Neurological Research · doi:10.1179/016164104225016272 · Cited by 213 · cited 1×
“The links between AD and cerebrovascular pathology [ 6 , 18, 44, 103], the association between cognitive impairment and cerebral amyloid angiopathy (CAA) present in up to 100% of AD brains [30, 47, 95], and the inXuence of AD pathology on the severity and topographic distribution of CAA have been discussed extensively…”
BackgroundAβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases
Pletnikova, O., West, N., Lee, M. K., Rudow, G. L., Skolasky, R. L., Dawson, T. M., Marsh, L., & Troncoso, J. C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.10.006 · Cited by 209
Lewy Body-Related α-Synucleinopathy in Aging
Saito, Y., Ruberu, N. N., Sawabe, M., Arai, T., Kazama, H., Hosoi, T., Yamanouchi, H., & Murayama, S. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.742 · Cited by 200
Patterns of levodopa response in Parkinson's disease: a clinico-pathological study
Kempster, P. A., Williams, D. R., Selikhova, M., Holton, J., Revesz, T., & Lees, A. J. (2007) · Brain · doi:10.1093/brain/awm142 · Cited by 191
Attems, J., Jellinger, K. A., & Lintner, F. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1064-y · Cited by 188
Self-citationArai, Y., Yamazaki, M., Mori, O., Muramatsu, H., Asano, G., & Katayama, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03082-1 · Cited by 173
Lashley, T., Holton, J. L., Gray, E., Kirkham, K., O’Sullivan, S. S., Hilbig, A., Wood, N. W., Lees, A. J., & Revesz, T. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0336-0 · Cited by 172
The enigma of vascular cognitive disorder and vascular dementia
Jellinger, K. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0185-2 · Cited by 166
Self-citationAmygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia
Junqué, C., Ramírez‐Ruiz, B., Tolosa, E., Summerfield, C., Martí, M., Pastor, P., Gómez‐Ansón, B., & Mercader, J. M. (2005) · Movement Disorders · doi:10.1002/mds.20371 · Cited by 165
Mikolaenko, I., Pletnikova, O., Kawas, C. H., O'Brien, R., Resnick, S. M., Crain, B., & Troncoso, J. C. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.156 · Cited by 159
Neumann, M., M�ller, V., G�rner, K., Kretzschmar, H. A., Haass, C., & Kahle, P. J. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0834-2 · Cited by 151
Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease
Jellinger, K. A., & Attems, J. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.018 · Cited by 148
Self-citationPrevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study
Jellinger, K. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0676-3 · Cited by 144
Self-citationAttems, J., Quass, M., Jellinger, K. A., & Lintner, F. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.01.013 · Cited by 140
Self-citationRegional Distribution of α-Synuclein Pathology in Unimpaired Aging and Alzheimer Disease
Parkkinen, L., Soininen, H. S., & Alafuzoff, I. I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.363 · Cited by 139
Schmidt, M. L., Martin, J. A., Lee, V. M. ‐., & Trojanowski, J. Q. (1996) · Acta Neuropathologica · doi:10.1007/s004010050454 · Cited by 138
Burton, E. J., McKeith, I. G., Burn, D. J., Firbank, M., & O'Brien, J. T. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000236596.56982.1c · Cited by 135
Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study
Jellinger, K. A., & Attems, J. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0634-5 · Cited by 133
Self-citationPopescu, A., Lippa, C. F., Lee, V. M. ‐., & Trojanowski, J. Q. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1915 · Cited by 132
del Ser, T., Hachinski, V., Merskey, H., & Muñoz, D. G. (2001) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200101000-00005 · Cited by 126
Vascular parkinsonism--an important cause of parkinsonism in older people
Thanvi, B., Lo, N., & Robinson, T. (2005) · Age and Ageing · doi:10.1093/ageing/afi025 · Cited by 124
Alpha‐Synuclein induces hyperphosphorylation of Tau in the MPTP model of Parkinsonism
Duka, T., Rusnak, M., Drolet, R. E., Duka, V., Wersinger, C., Goudreau, J. L., & Sidhu, A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6092com · Cited by 121
Biochemical Staging of Synucleinopathy and Amyloid Deposition in Dementia With Lewy Bodies
Deramecourt, V., Bombois, S., Maurage, C., Ghestem, A., Drobecq, H., Vanmechelen, E., Lebert, F., Pasquier, F., & Delacourte, A. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000205145.54457.ea · Cited by 111
The impact of cerebrovascular lesions in Alzheimer disease: A comparative autopsy study
Jellinger, K. A., & Mitter-Ferstl, E. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0142-0 · Cited by 111
Self-citationJellinger, K. A. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0822-z · Cited by 96
Self-citationCommon Inflammatory Mechanisms in Lewy Body Disease and Alzheimer Disease
Mrak, R. E., & Griffin, W. S. T. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812503e1 · Cited by 91
Mark, M. H., Sage, J. I., Walters, A. S., Duvoisin, R. C., & Miller, D. C. (1995) · Movement Disorders · doi:10.1002/mds.870100408 · Cited by 83
Marui, W., Iseki, E., Uéda, K., & Kosaka, K. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00327-5 · Cited by 78
Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism
Jellinger, K. A., & Attems, J. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00665.x · Cited by 77
Self-citationDementia with Lewy bodies from the perspective of tauopathy
Iseki, E., Togo, T., Suzuki, K., Katsuse, O., Marui, W., de Silva, R., Lees, A. J., Yamamoto, T., & Kosaka, K. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0644-3 · Cited by 72
Bancher, C., Egensperger, R., Kösel, S., Jellinger, K. A., & Graeber, M. B. (1997) · Acta Neuropathologica · doi:10.1007/s004010050726 · Cited by 72
Self-citationPrevalence of amyloid‐β deposition in the cerebral cortex in Parkinson's disease
Mastaglia, F. L., Johnsen, R. D., Byrnes, M. L., & Kakulas, B. A. (2002) · Movement Disorders · doi:10.1002/mds.10295 · Cited by 70
Iseki, E., Marui, W., Kosaka, K., & Uéda, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00178-0 · Cited by 65
The Lewy body variant of Alzheimer disease
Hansen, L. A. (1997) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6846-2_7 · Cited by 62
Haugarvoll, K., Aarsland, D., Wentzel‐Larsen, T., & Larsen, J. O. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00389.x · Cited by 57
Olichney, J., Ellis, R. J., Katzman, R., Sabbagh, M. N., & Hansen, L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48511.x · Cited by 57
Cerebral amyloid angiopathy and dementia.
Tian, J., Shi, J., & Mann, D. M. A. (2004) · PubMed · Cited by 55
Cerebral amyloid angiopathy in Lewy body disease
Jellinger, K. A., & Attems, J. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0856-8 · Cited by 52
Self-citationα-Synuclein: A potent inducer of tau pathology
Geddes, J. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.002 · Cited by 50
Amyloid β‐peptide and the dementia of Parkinson's diease
Jendroska, K., Lees, A. J., Poewe, W. H., & Daniel, S. E. (1996) · Movement Disorders · doi:10.1002/mds.870110609 · Cited by 49
Matthews, B. R. (2013) · Seminars in Neurology · doi:10.1055/s-0033-1359311 · Cited by 48
The role of α-synuclein and tau in neurodegenerative movement disorders
Wenning, G. K., & Jellinger, K. A. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000168241.53853.32 · Cited by 46
Self-citationShao, C., Crary, J. F., Rao, C., Sacktor, T. C., & Mirra, S. S. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000218441.00040.82 · Cited by 46
Prevalence of vascular lesions in Dementia with Lewy Bodies. A postmortem study
Jellinger, K. A. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0824-x · Cited by 45
Self-citationThe morphological basis of mental dysfunction in Parkinson's disease
Jellinger, K. A. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.002 · Cited by 44
Self-citationα-Synuclein, Aβ and Alzheimer's disease
Wirths, O., & Bayer, T. A. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00339-1 · Cited by 44
Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease
Trembath, Y., Rosenberg, C., Ervin, J. F., Schmechel, D. E., Gaskell, P. C., Pericak‐Vance, M. A., Vance, J. M., & Hulette, C. M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0670-9 · Cited by 42
Amyloid angiopathy in diffuse Lewy body disease
Wu, E., Lipton, R. B., & Dickson, D. W. (1992) · Neurology · doi:10.1212/wnl.42.11.2131 · Cited by 40
White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia
Marshall, G. A., Shchelchkov, E., Kaufer, D., Ivanco, L. S., & Bohnen, N. I. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00553.x · Cited by 37
Kumaran, R., Kingsbury, A. E., Coulter, I. C., Lashley, T., Williams, D. R., de Silva, R., Mann, D. M. A., Révész, T., Lees, A. J., & Bandopadhyay, R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.012 · Cited by 35
Kallhoff, V., Peethumnongsin, E., & Zheng, H. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-6 · Cited by 35
Relation of cerebral small‐vessel disease and brain atrophy to mild parkinsonism in the elderly
Reitz, C., Trenkwalder, C., Kretzschmar, K., Roesler, A., von Eckardstein, A., & Berger, K. (2006) · Movement Disorders · doi:10.1002/mds.21085 · Cited by 33
Lippa, S. M., Lippa, C. F., & Mori, H. (2005) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750502000506 · Cited by 32
The distribution of cerebrovascular amyloid in Alzheimer’s disease varies with ApoE genotype
Trembath, D., Ervin, J. F., Broom, L., Szymanski, M., Welsh-Bohmer, K., Pieper, C., & Hulette, C. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0162-9 · Cited by 31
Lippa, C. F. (2004) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750401900606 · Cited by 29
Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
Papapetropoulos, S., LIEBERMAN, A. N., Gonzalez, J. S., & Mash, D. C. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00411.x · Cited by 28
Guerini, F., Frisoni, G. B., Bellwald, C., Rossi, R., Bellelli, G., & Trabucchi, M. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52064.x · Cited by 21
Correlation of Entorhinal Amyloid with Memory in Alzheimer’s and Vascular but Not Lewy Body Dementia
Thomas, A. J., Ballard, C. G., Kenny, R. A., O'Brien, J. T., Oakley, A. E., & Kalaria, R. N. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000082349 · Cited by 21
Dementia in Parkinson's disease
Martí, M. J., TOLOSA, E. S., & de la Cerda, A. (2007) · Journal of Neurology · doi:10.1007/s00415-007-5007-5 · Cited by 11
Neuropathologic Changes in Parkinson Disease With Late Onset of Dementia
Jellinger, K. A., Seppi, K., & Wenning, G. K. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.452-a · Cited by 11
Self-citationMastaglia, F. L., Masters, C. L., Beyreuther, K. T., & Kakulas, B. A. (1989) · PubMed · Cited by 8
Cited by
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
Irwin, D. J., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3549 · Cited by 869
Iranzo, A., Tolosa, E., Gelpi, E., Molinuevo, J. L., Valldeoriola, F., Serradell, M., Sanchez-Valle, R., Vilaseca, I., Lomeña, F., Vilas, D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70056-5 · Cited by 723
Metadata
- Authors
- Jellinger, K. A., & Attems, J.
- Venue
- Acta Neuropathologica
- Published
- 2008-02-14
- Volume
- 115
- Issue
- 4
- Pages
- 427-436
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2022163854
- Cited by
- 268
- References
- 98
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.